Keybank National Association Sage Therapeutics, Inc. Transaction History

Keybank National Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$81.94 - $139.71 $153,063 - $260,978	-1,868 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $16,432 - $20,771	108 Added 6.14%	1,868 $301,000
Q4 2017 Feb 08, 2018	SELL	$60.72 - $167.34 $90,108 - $248,332	-1,484 Reduced 45.75%	1,760 $290,000
Q3 2017 Nov 02, 2017	SELL	$61.4 - $88.52 $34,015 - $49,040	-554 Reduced 14.59%	3,244 $202,000
Q2 2017 May 14, 2018	BUY	N/A	363 Added 10.57%	3,798 $302,000
Q1 2017 May 14, 2018	BUY	N/A	3,435	3,435 $244,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $330M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.